This year's program features conversations moderated by STAT's award-winning journalists, and we've just added a session focused on one of the hottest issues of the moment: the future of the FDA. It will feature former FDA commissioner Scott Gottlieb, former director of the Center for Drug Evaluation and Research Richard Pazdur, and Julie Tierney, principal at Leavitt Partners.
Plus, hear from Alnylam Pharmaceuticals CEO Yvonne Greenstreet, and join Adam Feuerstein as he interviews top investors Agustin Mohedas and Roderick Wong.
End the biggest biotech day of the year in great company with a packed STAT audience and an amazing evening of content. Don't wait to register. Capacity is limited and tickets are expected to sell out very quickly.
No comments